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The coordinated production of leukocytes in bone marrow is crucial for innate and adaptive 
immunity. Inflammation alters normal leukocyte production by promoting granulopoiesis 
over lymphopoiesis, a response that supports the reactive neutrophilia that follows 
infection. Here we demonstrate that this specialization for granulopoiesis is determined by 
inflammation-induced reductions of growth and retention factors, most significantly stem 
cell factor and CXCL12, which act preferentially to inhibit lymphoid development. These 
hierarchical effects suggest that the normal equilibrium of leukocyte production in bone 
marrow is determined by lymphopoiesis’ higher demand for specific growth factors and/or 
retention signals. Inflammation regulates this balance by reducing growth factors that have 
less impact on developing neutrophils than lymphocytes. We demonstrate that granulopoiesis 
and lymphopoiesis are coupled specifically in the bone marrow by development in a common 
niche and propose that the leukopoietic equilibrium is specified by limiting amounts of 
developmental resources.
 
Neutrophils develop through proliferative, then
nonmitotic stages in BM (1). Mature neutrophils
are short-lived and localize rapidly to inflamma-
tory sites where they deliver microbicidal activity
(2, 3). This localization produces a brief neutro-
penia that is corrected by accelerated emigration
of BM neutrophils, and subsequently, a reactive
neutrophilia that is characterized by abundant,
less mature cells (1). Reactive neutrophilia is a
crucial component of innate immunity because
persistent neutropenia leads to death by infection
(4, 5).
The BM regulates the homeostatic release
of mature neutrophils and the accelerated
production of granulocytes in response to in-
flammatory signals (6, 7). However, the mecha-
nisms of this regulation is unknown. We (8) and
others (9) have shown that infection, adjuvants,
or proinflammatory cytokines, especially TNF
 
 
 
and IL-1
 
 
 
, substantially reduce the numbers
of lymphocytes, but not Gr-1
 
 
 
 granulocytes,
in BM. These depletions correspond with
mobilization of BM lymphocytes and con-
comitant reductions in CXCL12 levels (8).
Pertussis toxin (PTX) also mobilizes BM
lymphocytes with little effect on the numbers
of Gr-1
 
 
 
 BM cells (8), which suggests that
G-protein–coupled signals control the retention
of lymphocytes but not granulocytes in the BM.
We have proposed that inflammation-
induced emigration of lymphocytes from BM
represents a physiologic response to ensure in-
creased neutrophil production in response to
infection, albeit at the expense of central B lym-
phopoiesis (8). That inflammation might control
BM granulopoiesis and lymphopoiesis indepen-
dently via reductions in CXCL12 expression
was a surprising observation; mice deficient for
CXCL12 or its receptor, CXCR4, share severe
impairments of B lymphocyte and granulocyte
production (10–12) that could reflect a common
mechanism to localize lymphocyte and granulo-
cyte progenitors in the BM (13).
Here, we show that immature neutrophils
in BM are relatively resistant to the inflammatory
signals that mobilize lymphocytes and mature
neutrophils. Inflammation specifically reduces
BM stem cell factor (SCF) and CXCL12 to
levels that do not support lymphopoiesis but
remain sufficient for continued granulopoiesis.
Reactive neutrophilia is the consequence of
the expansion of the immature, proliferating
neutrophil compartments into BM niches that
are vacated by lymphocytes and mature neu-
trophils. The reciprocal dynamics of the BM
lymphocyte and neutrophil populations are
consistent with cellular competition within a
developmental niche that is defined by a com-
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mon location and shared growth resources. Blocking BM
lymphopoiesis results in the specific and reciprocal expansion
of the granulocytic compartments of BM, with no effect on
other hematopoietic lineages. Thus, inflammation regulates
the normal balance of granulopoiesis and lymphopoiesis in
BM by suppressing common growth factors that affect lym-
phopoiesis more strongly than granulopoiesis.
 
RESULTS
Three neutrophil compartments in BM
 
Granulocytes in mouse BM can be categorized into increas-
ingly mature subsets on the basis of nuclear and granular
morphology, or by the expression of CD11b and the RB6-
8C5 antigen (Ag; 14, 15). mAbs that are specific for CD11b
and the RB6-8C5 Ag (Gr-1
 
 
 
) identify three distinct double-
positive populations in naive BL/6 mice: CD11b
 
int
 
Gr-1
 
int
 
,
CD11b
 
lo
 
Gr-1
 
hi
 
, and CD11b
 
hi
 
Gr-1
 
hi
 
 (Fig. 1 A). The CD11b
 
int
 
Gr-1
 
int
 
 cell population expressed significantly higher levels of
c-Kit and CD16/32, both markers of developmental imma-
turity (Fig. 1 A). The neutrophil-specific mAb NIMP-R14
(16) efficiently labeled the CD11b
 
lo
 
Gr-1
 
hi
 
 and CD11b
 
hi
 
Gr-1
 
hi
 
cells and bound a subset (60%) of the CD11b
 
int
 
Gr-1
 
int
 
 com-
partment (unpublished data).
After sorting to high purity, CD11b
 
int
 
Gr-1
 
int
 
 cells were
found to be primitive, with little nuclear condensation and
azureophilic cytoplasm (Fig. 1 B). The morphology of
CD11b
 
int
 
Gr-1
 
int
 
 cells is consistent with that of promyelocytes
and myelocytes (with occasional metamyelocytes; reference
17), the mitotic progenitors of all granulocytes. CD11b
 
hi
 
Gr-
1
 
hi
 
 cells were identical to mature peripheral neutrophils,
whereas CD11b
 
lo
 
Gr-1
 
hi
 
 cells represented an intermediate
stage of neutrophil maturation (metamyelocytes and band
forms) with faintly stained cytoplasm and incompletely con-
densed, ring-shaped nuclei (Fig. 1 B; reference 17).
Proliferating cells in each neutrophil population were iden-
tified by determining the DNA content in fixed and permeabi-
lized cells (Fig. 1 C; reference 18). Consistent with its expres-
sion of c-Kit and morphology, the CD11b
 
int
 
Gr-1
 
int
 
 population
contained a high frequency (24 vs. 3%) of proliferating cells
(Fig. 1 C). As controls, 19% of IgM
 
 
 
B220
 
lo
 
 pro-/pre-B cells
were in cycle compared with 6% in the mature, IgM
 
 
 
B220
 
hi
 
population (Fig. 1 C). Thus, CD11b and Gr-1 expression
reveal three increasingly mature granulocyte populations.
CD11b
 
int
 
Gr-1
 
int
 
 cells are mitotically active promyelocytes and
myelocytes; CD11b
 
lo
 
Gr-1
 
hi
 
 cells are nondividing, immature
neutrophils; and CD11b
 
hi
 
Gr-1
 
hi
 
 cells are mature neutrophils.
 
Reciprocal dynamics of BM lymphocyte and
granulocyte populations
 
Inflammation mobilizes lymphocytes from the BM without
reducing Gr-1
 
 
 
 cell numbers (8). The subsequent granulo-
 
Figure 1. Definition of neutrophil subsets in the BM of naive 
C57BL/6 mice.
 
 BM cells were labeled with mAbs specific for mouse 
CD11b, CD16/32, c-Kit, or RB6-8C5 Ags. Labeled cells were analyzed/
sorted by flow cytometry. Data represent three determinations with two 
mice/group (
 
n
 
 
 
 
 
 6). (A) Expression of CD11b and the RB6-8C5 Ag identifies 
three populations of double-positive cells: CD11b
 
int
 
Gr-1
 
int
 
, CD11b
 
lo
 
Gr-1
 
hi
 
, 
and CD11b
 
hi
 
Gr-1
 
hi
 
. These populations expressed distinct levels of CD40, 
c-Kit, F4/80, and CD16/32 (blue) as compared with nonspecific, isotype-
matched control Abs (red). (B) Sorted CD11b
 
int
 
Gr-1
 
int
 
, CD11b
 
lo
 
Gr-1
 
hi
 
, and 
CD11b
 
hi
 
Gr-1
 
hi
 
 BM cells after Giemsa staining. CD11b
 
int
 
Gr-1
 
int
 
 cells exhibit 
the morphology of promyelocytes and myelocytes; CD11b
 
lo
 
Gr-1
 
hi
 
 and 
CD11b
 
hi
 
Gr-1
 
hi
 
 cells represent increasingly mature cell forms. (C) Fraction 
of BM neutrophil and B cell populations in the G
 
2
 
 and S phases of the cell 
cycle. Among the BM granulocyte compartments, only CD11b
 
int
 
Gr-1
 
int
 
 
promyelocytes and myelocytes exhibit significant levels of mitosis. The 
DNA content of single cells in each phenotypic compartment was deter-
mined by intracellular propidium iodide
 
 
 
staining. Bars represent the average 
fraction (
 
 
 
SD) of cells in the G
 
2
 
 and S phases of the cell cycle. 
JEM VOL. 201, June 6, 2005
 
1773
 
ARTICLE
Figure 2. Immunization with adjuvant depletes mature, but not 
immature, neutrophils from BM. (A) Population dynamics of BM neutro-
phil and B cell subsets after immunization. 4 to 16 d after immunization, BM 
cells from C57BL/6 mice (n   4–6) were recovered and labeled with mAb 
specific for CD11b, the RB6-8C5 Ag, or B220. CD11bintGr-1int, CD11bloGr-1hi, 
and CD11bhiGr-1hi neutrophils and B220lo and B220hi lymphocytes were 
enumerated by flow cytometry to determine the effects of immunization on 
each population. CD11bintGr-1int and CD11bloGr-1hi cell numbers expand and 
contract reciprocally to B220lo B cells. Points represent average ( SEM) 
numbers of Gr-1int ( ), Gr-1hi ( ), B220lo ( ), or B220hi ( ) cells from a 
tibia and femur at the times indicated; naive controls are shown (day 0). 
(B) FACS profiles of CD11b Gr-1  and B220  BM cell populations before 
(left), and 4 d after (right) immunization represent three independent exper-
iments with two mice/group (n   6). Immunization reduces the CD11bhiGr-1hi 
neutrophil subset and both B220lo and B220hi lymphocytes, but expands 
CD11bintGr-1int and CD11bloGr-1hi cell sets.
 
matopoiesis (8). To investigate these possibilities, we fol-
lowed the dynamics of developing and mature neutrophils
and lymphocytes in the BM after immunization (Fig. 2).
4 d after immunization, the proliferating CD11b
 
int
 
Gr-1
 
int
 
neutrophil compartment grew three- to fourfold, whereas the
mature CD11b
 
hi
 
Gr-1
 
hi
 
 populations changed little (Fig. 2 A);
coincidentally, B220
 
lo
 
 and B220
 
hi
 
 cell numbers decreased ap-
proximately threefold (Fig. 2 A; reference 8). The reciprocal
behavior between CD11b
 
int
 
Gr-1
 
int
 
 neutrophils and B220
 
 
 
lymphocytes was repeated subsequently; as B220
 
 
 
 BM cell
numbers returned to normal, the expanded, immature neu-
trophil compartments diminished (days 8 and 12; Fig. 2 A).
In contrast with the rapid changes in B220
 
 
 
 lymphocyte
and CD11b
 
int
 
Gr-1
 
int
 
 neutrophil numbers, the mature neu-
trophil compartment of BM is more stable. In naive mice, a
tibia and femur contain 
 
 
 
7 
 
 
 
 10
 
6
 
 CD11b
 
hi
 
Gr-1
 
hi
 
 neutro-
phils; 4 d after immunization that number increases 
 
 
 
40%,
and by day 12 doubles to 
 
 
 
1.4 
 
 
 
 10
 
7
 
 (Fig. 2 A).
Adjuvant-induced expansion of the BM’s primitive gran-
ulocytic compartment includes the c-Kit
 
 
 
CD11b
 
int
 
Gr-1
 
int
 
cell subset and occurs even as c-Kit
 
 
 
 pro–B cells are lost
from BM (Fig. 2 B; reference 8). This reciprocity suggests a
regulatory mechanism that acts by reducing lymphopoietic
resources while sparing factors that are important for granu-
locyte development.
 
Inflammation differentially modulates growth factors in BM
 
The inflammation-induced emigration and subsequent recov-
ery of BM lymphocytes correlates with changes in CXCL12
mRNA and protein expression (8). Mindful that CXCL12 is
crucial for granulocytic and lymphoid progenitors to colonize
the BM (11–13), we used quantitative RT-PCR to identify
differentially regulated factors that might expand granulopoie-
sis in BM that is transiently deficient in CXCL12.
mRNA specific for B cell–activating factor (BAFF),
CXCL2, CXCL12, GAPDH, GM-CSF, hypoxanthine-gua-
nine phosphoribosyltransferase (HPRT), IL-1
 
 , IL-3, IL-7,
and SCF were quantified relative to GAPDH message at var-
ious times after immunization (Table I and Fig. 3 A). As ex-
pected, CXCL12 message decreased  10-fold at days 4 and
8 after immunization (8); recoveries to 50% of naive levels
were achieved by day 12; and 16 d after immunization,
CXCL12 mRNA levels were  10-fold higher than naive
controls (Fig. 3 A). SCF mRNA followed a similar kinetics,
and decreased 10-fold by day 4 and recovered to supranor-
mal levels by day 16. Immunization decreased BAFF and
IL-7 message levels by not  50%, a decrease that also was
observed in the HPRT control (Fig. 3 A). However, al-
though HPRT message returned to naive levels, mRNA
that was specific for IL-7 and BAFF became elevated (170%
and 400% of naive controls, respectively) 16 d after immuni-
zation. Overexpression of CXCL12, SCF, BAFF, and IL-7
in BM coincides with recovery of central B lymphopoiesis
and a return to normal levels of granulocyte production (Fig.
2 A; reference 8).
cytosis that was elicited by inflammatory stimuli could result
from a specific expansion of granulocytic progenitors or a
general enhancement of the ability of BM to support he-RECIPROCAL PRODUCTION OF GRANULOCYTES AND LYMPHOCYTES | Ueda et al. 1774
In contrast, mRNAs that are specific for IL-1  and
CXCL2, a potent activator of granulopoiesis (19) and neu-
trophil chemokines (20), respectively, were not changed sig-
nificantly by immunization until day 12; both then decreased
to 30–40% of naive levels. mRNA levels in BM for two im-
portant myelopoietic growth factors, IL-3 and GM-CSF,
were below the detection limit ( 10 5 GAPDH levels; Ta-
ble I) of our PCR assay.
Inflammatory reductions of CXCL12 message in BM
correlate with lower levels of CXCL12 protein (8). To de-
termine if reduced SCF mRNA also decreased BM SCF
protein, SCF in the BM plasma (BMp) of naive and immu-
nized mice (day 4; n   4) was quantified by ELISA. SCF
levels in naive mice averaged 163 pg/ml BMp; BMp from
immunized mice contained only 35 pg/ml SCF,  21% of
control levels (unpublished data).
To determine whether reductions in SCF and CXCL12
expression might depress lymphopoiesis while sparing granu-
lopoiesis, we determined the effects of reduced c-Kit signaling
on the proliferation and differentiation of common lympho-
cyte progenitors (CLP) and common myeloid progenitors
(CMP) in vitro (21, 22). In brief,  100 CLP or CMP were
introduced into established cultures of adherent BM cells that
were supplemented with lymphoid or myeloid growth fac-
tors. PTX or antagonistic mAb specific for LFA-1 or c-Kit
were added to replicate cultures. 4 d later, the effects of these
treatments on CLP and CMP differentiation were determined
by enumerating B220  and Gr-1  cells (Fig. 3 B).
PTX efficiently inhibits proliferation of CLP and CMP,
and reduces the production of differentiated B220  and
Gr-1  cells to  50% of control cultures (Fig. 3 B). Al-
though mAb to LFA-1 had little effect (P   0.05) on CLP
or CMP cultures, addition of c-Kit mAb significantly in-
hibited (P  0.01) B220  cell production from CLP (27%
of controls), but had little activity in CMP cultures (80% of
controls; Fig. 3 B).
Similarly, whereas B220lo and Gr-1int cells migrated to
BMp in vitro, lymphocyte migration was inhibited by mAb
to CXCL12 far more effectively (13% of controls; P   0.04)
than granulocyte migration ( 50% of controls; P   0.05),
despite the greater sensitivity of Gr-1int cells to the dilute
source of chemoattractant (Fig. 3 C; reference 8). mAb to
CXCL5 had no effect on B220lo or Gr-1int cell migration. In
these in vitro assays, SCF and CXCL12, two BM growth
factors specifically diminished by inflammation (Fig. 2), pref-
erentially affect lymphocyte progenitors.
Homing of immature neutrophils to BM is PTX resistant
The different effects of anti-CXCL12 on the ability of de-
veloping B cells and neutrophils to migrate toward BMp
(Fig. 3 C) suggest distinct sensitivities to G i signals. Al-
CXCL5 (n   2). However, mAb specific for CXCL12 suppresses the migra-
tion of B220lo cells (13% of BMp control) more than Gr-1int cells (50% of 
BMp control; n   5–7). *P   0.05; **P  0.01.
Figure 3. Inflammation modulates the expression of lymphoid, but 
not myeloid, growth factors in the BM. (A) Immunization strongly 
( 10-fold) reduced steady-state levels of mRNA specific for CXCL12 and 
SCF; relative to HPRT, BAFF and IL-7 message levels were not suppressed 
significantly. By 16 d after immunization, mRNA levels for lymphocyte 
growth factors were supranormal. mRNA specific for various growth fac-
tors was quantitated in reference to GAPDH message present in the same 
sample. Each point (n   2–5) represents the average ( SD) amount of 
specific mRNA relative to mean levels present in naive controls. Levels of 
mRNA for GM-CSF and IL-3 were below the limits of detection. (B) Re-
duced c-Kit signaling preferentially inhibits proliferation/survival and dif-
ferentiation of CLP over CMP. 100 CLP or CMP were cultured on adherent 
BM cell layers in media supplemented with hematopoietic growth factors 
(n   2–3). PTX, or mAb specific for LFA-1 or c-Kit were added to cultures 
to determine the effect of reduced c-Kit signaling on lymphopoiesis and 
myelopoiesis. PTX inhibits lymphopoiesis and myelopoiesis equally but an-
tagonistic anti–c-Kit mAb preferentially suppressed only the CLP cultures. 
(C) Preferential inhibition of chemotaxis of B220lo and Gr-1int BM cells by 
anti-CXCL12 mAb. In vitro, B220lo and Gr-1int BM cells migrate to BMp. 
This migration is abrogated completely by PTX and unaffected by mAb to JEM VOL. 201, June 6, 2005 1775
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though PTX depletes the BM of lymphocytes, it increases
the numbers of Gr-1  BM cells (8).
To determine the relative importance of G i signaling in
the homing of BM lymphocytes and granulocytes, we incu-
bated BM cells (1.5   107) from B6.SJL mice (CD45.1) in
media which contained 0, 25, or 100 ng/ml of PTX and
then injected them into BL/6 (CD45.2) recipients. The next
day, we enumerated CD45.1  neutrophils and B cells in BM
to determine homing efficiencies.
CD45.1 Gr-1  and CD45.1 IgM B220lo cells were de-
tected easily in recipient BM 14 h after transfer of untreated
cells; treatment with PTX reduced the homing efficiency
of mature CD45.1 CD11bhiGr-1hi neutrophils and IgM 
B220lo pro–/pre–B cells more than fivefold (Fig. 4). In con-
trast, pretreatment with PTX resulted in nonsignificant,
twofold reductions in the numbers of CD45.1 CD11bintGr-
1int pro-/myelocytes that returned to the BM (Fig. 4). Hom-
ing by immature, CD45.1 CD11bloGr-1hi neutrophils also
was resistant to PTX. Doses of PTX that abrogated BM re-
entry by mature, CD11bhiGr-1hi neutrophils and B220lo
lymphocytes reduced homing by immature neutrophils
 20% (Fig. 4). Thus, CD11bintGr-1int and CD11bloGr-1hi
granulocytes localize in BM by a mechanisms that is rela-
tively insensitive to disruption of G i-coupled signaling;
homing by B220lo lymphocytes and mature, CD11bhiGr-1hi
neutrophils is PTX-sensitive.
A common niche for B220  and Gr-1  cell development
The reciprocal expansion of the Gr-1int BM compartment fol-
lowing adjuvant-induced emigration of B220  lymphocytes
(Fig. 2; reference 8) suggested to us that granulocytes and
lymphocytes might occupy a common developmental niche.
If so, Gr-1int and B220lo cells must co-locate within the BM.
Histologic sections of femurs from naive mice (Fig. 5 A) dem-
onstrate that Gr-1  and B220  cell clusters are interspersed
closely. 4 d after immunization, expansion by Gr-1  cell clus-
ters is obvious, whereas B220  lymphocyte clusters become
rare (Fig. 5 B). The proximity of granulocytes and B lympho-
cytes in the BM is consistent with a shared developmental
niche but does not exclude the possibility of a tight mosaic of
sites that is specific for myelo- or lymphopoiesis.
To determine whether granulocytes and B lymphocytes
can develop within a common microenvironment, we pre-
pared cultures of BM stromal cells free of hematopoietic
progenitors (23) and seeded them with autologous c-Kit 
B220lo and c-Kit Gr-1int cells labeled by carboxyfluorescein
Table I. RT-PCR primers and relative message levels for lymphoid and myeloid growth factors in the BM of naive mice
Gene Primers Relative levels mRNA in BM of naive micea
HPRT forward 5 -GCTGGTGAAAAGGACCTCT-3  1.76   0.45   100
reverse 5 -CACAGGACTAGAACACCTGC-3  CT   21.3   0.2b
GAPDH forward 5 -AACTTTGGCATTGTGGAAGG-3  1.00   100
reverse 5 -ACACATTGGGGGTAGGAACA-3  CT   22.4   2.3
BAFF forward 5 -TTCCATGGCTTCTCAGCTTT-3  3.07   1.00   10 1
reverse 5 -GGAATTGTTGGGCAGTGTTT-3  CT   23.9   0.4
SCF forward 5 -CGGGAATCCTGTGACTGATAA-3  6.16   2.03   10 3
reverse 5 -GGCCTCTTCGGAGATTCTTT-3  CT   29.5   0.4
CXCL12 forward 5 -GTCCTCTTGCTGTCCAGCTC-3  3.95   1.53   10 3
reverse 5 -TAATTTCGGGTCAATGCACA-3  CT   30.3   4.0
IL-1  forward 5 -GACCTTCCAGGATGAGGACA-3  8.74   0.28   10 4
reverse 5 -AGGCCACAGGTATTTTGTCG-3  CT   32.6   0.2
IL-7 forward 5 -TGGAATTCCTCCACTGATCC-3  4.93   1.75   10 4
reverse 5 -ACCAGTGTTTGTGTGCCTTG-3  CT   33.1   0.3
CXCL2 forward 5 -AGTGAACTGCGCTGTCAATG-3  1.19   0.17   10 4
reverse 5 -AGGCACATCAGGTACGATCC-3  CT   36.1   0.7
IL-3 forward 5 -TAGGGAAGCTCCCAGAACCT-3   1.00   10 5
reverse 5 -TTAGGAGAGACGGAGCCAGA-3  NA
GM-CSF forward 5 -CATCAAAGAAGCCCTGAACC-3   1.00   10 5
reverse 5 -TGCATTCAAAGGGGATATCAG-3  NA
amRNA levels are standardized to GAPDH message; levels of a second housekeeping gene, HPRT, control for nonspecific changes in message levels.
bCT values represent average threshold cycle number ( SD) for amplifications of cDNA reverse transcribed from 0.025  g total RNA.
NA, not applicable.RECIPROCAL PRODUCTION OF GRANULOCYTES AND LYMPHOCYTES | Ueda et al. 1776
diacetate, succinimidyl ester (CFSE; green) or Cell Tracker
orange (CMRA; red). 1 d later, the numbers and distribu-
tions of B220  (CFSE/green) and Gr-1  (CMRA/red) cells
in cultures with and without stromal cell layers were identi-
fied by fluorescence microscopy.
In the absence of stromal cells, brightly fluorescent, non-
adherent B220  and Gr-1  cells were distributed uniformly
and relatively infrequent (Fig. 5 C). In the presence of stro-
mal cell layers, B220  and Gr-1  cell numbers were increased
substantially (not depicted) and many B220  and Gr-1  cells
had migrated beneath stromal cells to form “cobblestone
clusters” (Fig. 5 D). The majority of cobblestone clusters
contained B220  and Gr-1  cells that were dimly fluores-
cent and suggestive of cell division; mixed cell populations
often were beneath a single stromal cell and demonstrated
that c-Kit B220lo and c-Kit Gr-1int cells can develop in a
common microenvironment (Fig. 5 D).
If the B220  and Gr-1  BM compartments also share a
developmental niche in vivo, reductions in one lineage will
result in a specific and compensatory expansion of the other
(Fig. 2; reference 8). To test this prediction without disturb-
ing the cytokine milieu of BM (Fig. 4), we enumerated my-
eloid (Gr-1 ), lymphoid (B220 ), and erythroid (TER119 )
cells in the femurs of normal and RAG1-deficient mice. In
brief, BM cells from C57BL/6 (n   5) and congenic Rag-
1 /  mice (n   5) were labeled with fluorochrome-coupled
mAbs specific for the B220, TER119, or RB6-8C5 Ags; la-
beled and unlabeled cells from individual femurs were enu-
merated by flow cytometry.
On average, femurs from control mice contained 155.9  
15.9   105 nucleated cells comprising (all  10 5) 76.1
( 8.5) B220  cells; 42.9 ( 3.0) Gr-1  cells; 18.3 ( 4.6)
TER119  cells; and 18.5 (  2.6) unlabeled cells (Fig. 5
E). Femoral cell numbers in Rag-1 /  mice (130.6   13.4  
105) were significantly (P   0.002) lower than that of BL/6
controls, with all cell losses confined to B220  compart-
ments (Fig. 5 E). In RAG1-deficient BM, cells with a pre-/
pro-B phenotype were increased (from 2   105 to 10  
105), which was consistent with blockade of D-to-JH join-
ing (unpublished data; reference 24). Despite this expan-
sion, femurs of RAG1-deficient mice contained only one
third as many B220  cells (27.5   3.3   105 vs. 76.1  
105) as controls. Without compensating increases in other
BM cell compartments, femurs from RAG1-deficient
mice should have contained only  108   105 nucleated
cells.
Instead, losses in B220  BM cell numbers were offset by
increased numbers of Gr-1  cells. The mean number of
Gr-1  femoral cells in RAG1-deficient mice was signifi-
cantly higher (P   0.001) than in controls; they increased
from 42.9   3.0   105 cells to 62.9   9.5   105 cells. This
increase represented expansions in all neutrophil compart-
ments, including the proliferating CD11bintGr-1int cell subset
(P   0.01). Significantly, femurs from Rag-1 /  and control
mice contained virtually identical numbers of TER119 
(20.0   2.6   105 vs. 18.3   4.6   105, respectively; P  
0.36) and unlabeled cells (20.2   2.8   105 vs. 18.5  
2.6   105; P   0.21). Removal of BM lymphocytes by a
specific developmental blockade results in the compensatory
expansion by Gr-1  cells only. The specific and reciprocal
coupling between Gr-1  and B220  cell numbers and their
co-localization defines a common developmental niche for
BM granulocytes and lymphocytes.
DISCUSSION
Leukocyte production in the BM is controlled by inflam-
matory cytokines. In concert, TNF  and IL-1  induce the
loss of BM lymphocytes by emigration while significantly
expanding granulocyte production (8). This expansion is re-
alized by increasing CD11bintGr-1int pro-/myelocyte num-
bers (Fig. 1) in concordance with lymphocyte losses (Fig.
2). We conclude that the expansion of this generative,
CD11bintGr-1int compartment fuels the reactive CD11blo
Gr-1hi, CD11hibGr-1hi neutrophilia of inflammation and in-
fection (Figs. 1 and 2; references 3–5, 25).
Inflammation’s reciprocal effects on BM lymphopoiesis
and granulopoiesis could be coupled or independent; how-
ever, coupled regulation is the more parsimonious explana-
tion to link these leukocyte compartments. To identify an
inflammation-dependent mechanism that regulates granu-
lopoiesis and lymphopoiesis we assayed mRNA specific for a
variety of growth and localization factors (CXCL 12, CXCL
2, IL-1 , IL-3, IL-7, GM-CSF, SCF, BAFF) that influence
lymphocytes and neutrophils (Table I; Fig. 3). We observed
Figure 4. The ability of immature, CD11bintGr-1int and CD11bloGr-1hi 
granulocytes to home to the BM is resistant to PTX. BM cells from 
B6.SJL (CD45.1) mice were exposed to PTX, 0 ng/ml (n   3; open bars); 
25 ng/ml (n   4; filled bars); and 100 ng/ml (n   2; stippled bars) and 
injected into C57BL/6 (CD45.2) recipients. 14 h later, CD45.1  cells in host 
BM were enumerated by flow cytometry. Bars represent mean ( SD) 
numbers of CD45.1  cells; significant (P   0.05) changes from controls 
are indicated (*). Whereas exposure to 25 ng/ml PTX significantly reduced 
the numbers of transferred CD11bhiGr-1hi neutrophils and B220lo lympho-
cytes, homing by CD11bintGr-1int and CD11bloGr-1hi granulocytes was in-
hibited insignificantly (P   0.05), even after exposure to 100 ng/ml PTX.JEM VOL. 201, June 6, 2005 1777
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that inflammation’s effects on the BM are specific; immuni-
zation with adjuvant significantly reduced only CXCL12
and SCF, and these reductions correlated exactly with
the  depletion of BM lymphocytes and the expansion of
CD11bintGr-1int cell numbers (Fig. 3; reference 8). Although
our search for regulated factors was not exhaustive, it is sig-
nificant that in vitro and in vivo, reductions in CXCL12 and
SCF preferentially disturb CLP and B220lo lymphocyte de-
velopment and localization with no or lesser effects on CMP
and CD11bintGr-1int granulocytes (Figs. 3 and 4). Adult via-
ble c-Kit–deficient mice exhibit normal myelopoiesis with
little or no B-lymphopoiesis (26); administration of AMD-
3100, a specific antagonist of the CXCL12 receptor,
CXCR4, mobilizes CD34  human stem cells but not mye-
locytes or metamyelocytes (27). Given this biased activity,
how could reductions of CXCL12 and SCF effect granu-
lopoietic expansions?
An attractive possibility is that the reciprocal control of
granulopoiesis and lymphopoiesis reflects competition be-
tween the generative CD11bintGr-1int and B220lo compart-
ments in the BM. Thus, when inflammation reduces the ca-
pacity of the BM to retain lymphocytes and promote
lymphopoiesis (Figs. 3 and 4; reference 8), granulocyte pre-
cursors acquire increased resources for proliferation and/or
survival and expand into areas that are vacated by migrant
lymphocytes. A prediction of this hypothesis is that lympho-
cyte and granulocyte progenitors occupy and compete in a
common BM niche.
Histologic examination of femoral BM reveals B220 
and Gr-1  cells which are organized in small, adjacent clus-
ters (Fig. 5 A). Immunization with adjuvant alters this dis-
tribution by dramatically expanding Gr-1  cell areas and
reducing B220  cell zones (Fig. 5 B); these histologic
changes match the dynamics of the Gr-1  and B220  cell
numbers after immunization (Fig. 2). To determine
whether B lymphocyte and granulocyte development can
occur in a common microenvironment, we cultured
c-Kit B220lo and c-Kit Gr-1int cells with autologous BM
stromal cells that were depleted of hematopoietic activity
(23). These cultures supported large numbers of developing
leukocytes that had migrated beneath the stromal cell layer
to form cobblestone clusters. These clusters contained Gr-1 
and B220  cells, often beneath a single stromal cell body
(Fig. 5 D). The close association of B220  and Gr-1  cell
clusters in the BM (Fig. 5 A) and their adjacent develop-
ment in vitro (Fig. 5 D) provide strong support for our hy-
pothesis that these cell compartments share a developmental
niche in the BM.
If developing granulocytes and lymphocytes compete for
a BM niche, reductions in one compartment must result in
expansions by the other. We tested this prediction by com-
paring the numbers of cells belonging to three hematopoie-
tic lineages in the BM of Rag-1 /  mice and their normal,
congenic controls. Losses of B220  cells in the BM of
RAG1-deficient mice were compensated only by increased
numbers of Gr-1  cells; the numbers of TER119  erythroid
lineage and unlabeled cells in RAG1-deficient and control
mice were virtually identical (Fig. 5 E).
Our lymphocyte ablation experiment had three possible
outcomes (Fig. 6). If B220 , Gr-1 , and TER119  cells oc-
Figure 5. BM granulocytes and B lymphocytes share a common 
developmental niche. (A) The femoral BM of naive mice contains many 
closely associated Gr-1  (red) and B220  (green) cell clusters. (B) 4 d after 
immunization with adjuvants, the size of Gr-1  BM cell clusters is much 
increased; this expansion includes areas that formerly were occupied by 
B220  lymphocytes (see Fig. 1). (C) Culture of c-Kit Gr-1  (red) and
c-Kit B220  P (green) in the absence of BM stromal cell layers results in 
little or no proliferation and very limited development. (D) In the presence 
of stromal cell layers, c-Kit Gr-1  and c-Kit B220  cells migrate beneath 
stromal cell bodies to form cobblestone clusters that contain lymphocyte- 
and granulocyte precursors. (E) Hematopoietic compartments in the BM of 
Rag-1 /  and congenic C57BL/6 mice. Femoral BM cells from C57BL/6 
(n   5) and RAG1-deficient mice (n   5) were labeled with the Gr-1 mAb 
and mAbs specific for B220 and TER119; labeled and unlabeled BM cells 
from individual femurs were enumerated by flow cytometry. Control 
femurs contained an average of 156   105 nucleated cells (center), com-
prising  76   105 B220  cells, 43   105 Gr-1  cells, 18   105 TER119  
cells, and 19   105 unlabeled cells (outer segments). Femoral BM cell 
numbers in Rag-1 /  mice (center; 31   105) were significantly (P   0.002) 
lower than controls with losses confined to B220  compartments. Femurs 
of RAG1-deficient mice contained an average of only 28   105 B220  
cells but a compensating increase of Gr-1  cell numbers to 63   105 cells/
femur. In contrast, RAG1-deficient and control mice contained virtually 
identical numbers of TER119  and unlabeled cells.RECIPROCAL PRODUCTION OF GRANULOCYTES AND LYMPHOCYTES | Ueda et al. 1778
cupy separate BM niches, reduction in any one cellular com-
partment will not affect the others. Conversely, if all hemato-
poietic lineages compete generally in BM, losses in any one
compartment would be compensated by expansions of all of
the others. Neither of these outcomes was observed in
RAG1-deficient mice. Instead, reduced B220  cell numbers
expanded only the Gr-1  cell compartment. This specific and
reciprocal coupling between B220  and Gr-1  BM cell num-
bers defines a common developmental niche (Fig. 6) that may
be visualized in vitro and in vivo (Fig. 5). Granulopoiesis and
lymphopoiesis compete in the BM, whereas under these ex-
perimental conditions, erythropoiesis is independent of both.
The relative abundance of mRNAs for lymphoid growth
factors (Table I) suggests that lymphopoiesis and granu-
lopoiesis are balanced normally by a surfeit of growth re-
sources that are lymphoid-specific or -preferent (Figs. 3 and
4; Table I). If so, reductions in CXCL12 and SCF would re-
duce BM lymphocyte numbers directly but promote granu-
lopoiesis indirectly, by removing lymphocyte competitors.
Reductions in SCF (mimicked by inhibiting c-Kit signaling)
and CXCL12 primarily inhibit the activities of lymphocyte
progenitors (Figs. 3 and 4). These biased effects provide a
mechanism to shift the leukopoietic equilibrium in the BM
toward granulopoiesis and the support of neutrophilic re-
sponses to infection (4, 5).
The new leukopoietic equilibrium that is established by
inflammation may require additional signals to normalize.
We note that reestablishment of normal lymphopoietic levels
coincides with supranormal expression of lymphoid growth
factor genes and decreased IL-1  and CXCR2 message (Fig.
3). Excess lymphoid support may be necessary to restore
lymphoid progenitors to BM niches that are colonized by
progenitor and immature granulocytes, and thereby, reverse
increased granulopoiesis.
The reductions of BM CXCL12 and SCF elicited by the
proinflammatory cytokines, TNF  and IL-1  (8), preferen-
tially affect lymphopoiesis and lymphocytes over the other
hematopoietic compartments (Figs. 3 and 4). These differen-
tial effects and competition between the BM’s B220  and
Gr-1  compartments (Fig. 6) offer a simple, but robust,
mechanism for innate immunity to regulate granulopoiesis
and lymphopoiesis. During infection, acute granulocytic re-
sponses are crucial for host protection; in contrast to lym-
phocytes, mature granulocytes are very short-lived and are
incapable of proliferation, and effective granulocytic re-
sponses require expanded leukopoiesis in the BM.
Why does the specialization of the BM lead to peripheral
lymphopoiesis? We note that neutrophils, especially those
elicited by myelopoietic growth factors and/or proinflam-
matory cytokines, release large amounts of BAFF (28, 29).
Perhaps the reactive neutrophilia that is elicited by TNF 
and IL-1  amplifies extramedullary lymphopoiesis by in-
creasing local levels of BAFF to support cell survival and/or
differentiation to plasmacytes.
MATERIALS AND METHODS
Mice and immunizations. C57BL/6 (BL/6, CD45.2), congenic B6.SJL-
Ptprca/BoAiTac (B6.SJL, CD45.1), B6.129S7-Rag1tm1Mom/J were purchased
(Jackson ImmunoResearch Laboratories or Taconic Farms). Mice were
housed in specific pathogen-free conditions at the Duke University Animal
Care Facility and given sterile bedding, water, and food. Mice used in these
experiments were 6–18 wk of age; these studies were reviewed and approved
by the Duke University Institutional Animal Care and Use Committee.
Mice were immunized by i.p. injections of (4-hydroxy-3-nitrophe-
nyl)acetyl-chicken   globulin (50  g) emulsified in IFA (Sigma-Aldrich;
reference 23); (4-hydroxy-3-nitrophenyl)acetyl-chicken   globulin con-
tained 10 or 12 mol nitrophenyl/mol chicken   globulin.
Flow cytometry. FITC, PE, biotin, or allophycocyanin (APC), PE-
Cy5–conjugated mAb specific for mouse B220, IgM, CD11b, CD4, CD8,
CD40, TER119, Thy1.2, CD117, CD45.1, F4/80, or RB6-8C5 were
purchased from BD Biosciences or eBioscience. The Gr-1 mAb binds
RB6-8C5 Ag, a marker of granulocyte development (15). CD93-specific
493 mAb (30) was purified from culture supernatants in our laboratory.
Texas red (TXR) conjugates of antibody (Ab) for mouse IgM were pur-
chased from Southern Biotechnology Associates, Inc. We used the neutro-
phil-specific mAb, NIMP-R14 (16), to confirm histologic identification of
granulocyte subsets.
Mice were killed at various times after injection/immunization and sin-
gle cell suspensions were prepared from femur and tibia. Erythrocytes were
lysed in ammonium chloride buffer. For analysis, cells were suspended in
50–100  l of ice-cold HBSS containing 2% FCS and various combinations
of labeled antibodies for 20 min. 7-Aminoactinomycin D (Molecular
Probes) or propidium iodide (Sigma-Aldrich) was included to identify dead
cells. Labeled cells were analyzed in FACScan (488 nm argon laser) or
FACS Vantage SE (FACSDiVa digital option; 488 nm argon laser and 633
nm helium/neon laser) flow cytometers. For sorting, BM cell suspensions
Figure 6. Models for interaction between the B220 , Gr-1 , and 
TER119  hematopoietic compartments of BM. In normal femoral BM, 
B220  lymphocytes, Gr-1  granulocytes, and TER119  erythroid cells are 
present in stable ratios (4:2:1; Fig. 5 E) that define one of three possible 
relationships between these hematopoietic compartments: independence, 
general dependence, or specific dependence. In the case of independence 
(left), growth resources for each compartment are distinct and the com-
partments do not compete. Under these conditions, removal of the large 
B220  compartment by a lymphocyte-specific, developmental blockade 
would not alter the size/state of the other cell compartments. If all hemato-
poietic cell compartments share growth resources and are generally depen-
dent (center), reductions in B220  cell numbers would result in compensa-
tory increases in the Gr-1 and TER119 compartments. Specific dependence 
(right) between hematopoietic compartments exists when some, but not all, 
compartments compete for a growth resources. If the B220  and Gr-1  BM 
compartments share a developmental niche that excludes the erythroid lin-
eages, depletion of the B220  cells would result in compensatory increases 
in Gr-1 cell numbers without changes in the TER119 compartment. This 
outcome is observed in the BM of RAG1-deficient mice (Fig. 5 E).JEM VOL. 201, June 6, 2005 1779
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were labeled with fluorochrome-antibody conjugates; flow cytometric data
were analyzed with FlowJo software (Treestar Inc.).
Definition and isolation of BM cell populations. BM cells were la-
beled with FITC-conjugated Gr-1 mAb, PE- or TXR-conjugated anti-
IgM, and APC-conjugated anti-B220. CD11bhiGr-1hiIgM B220 ,
CD11bloGr-1hiIgM B220 , and CD11bintGr-1intIgM B220  cells were
doubly sorted to  98% purity in a FACS Vantage SE flow cytometer.
CMP and CLP were recovered from BM as described previously (21,
22). In brief, BM cells were labeled with PE-CY5–conjugated mAbs spe-
cific for CD4, CD8, TER119, Gr-1, CD11b, and B220. Labeled, Lin  cells
were depleted by incubation with anti-PE magnetic beads (Miltenyi Biotec;
GmbH). To isolate CMP, Lin  cell populations were stained with APC-
conjugated anti–c-Kit mAb, TXR-conjugated anti–Sca-1, FITC-conju-
gated anti-CD34, and PE-conjugated anti-CD16/32; CLP were identified
by labeling with APC-conjugated anti–c-Kit, TXR-conjugated anti–Sca-1,
FITC-conjugated anti-Thy1.2, and PE-conjugated anti–IL-7R. CMP and
CLP were recovered by sorting with a FACS Vantage SE flow cytometer.
Determination of cell cycle status. BM cells that were labeled by vari-
ous combinations of fluorochrome-mAb conjugates were fixed in 1% para-
formaldehyde at 4 C for 30 min and subsequently incubated with 1  g/ml
propidium iodide in 2% saponin/PBS at 4 C for 30 min. The DNA content
in various cell populations was determined by quantifying levels of bound
propidium iodide by flow cytometry (18). Cells containing 2N (G0/1) or
 2N levels (G2 and S) of DNA were enumerated. Doublet cells were ex-
cluded by forward and side-scatter gating (18).
Quantification of mRNA levels. mRNA from BM cells was precipi-
tated in Trizol reagent (Invitrogen) and reverse transcribed (Superscript II;
Invitrogen). Quantitative PCR amplifications of cDNA were performed in
an iCycler thermal cycler (Bio-Rad Laboratories) with SYBR Green PCR
core reagents (Applied Biosystems) and primers specific for BAFF, CXCL2,
CXCL12, GAPDH, GM-CSF, HPRT, IL-1 , IL-3, IL-7, or SCF tran-
scripts (Table I). Standard amplification parameters for the quantitative
PCR were as follows: initial denaturation at 94 C for 10 min; amplification
cycle; denaturation at 94 C for 45 s; and anneal/extension at 64 C for 45 s.
The relative expression levels for growth factor genes were calculated by the
comparative CT (threshold cycle) method recommended by the manufac-
turer (Applied Biosystems) normalized to GAPDH message in the same
sample. In brief,  CT values were determined by subtracting CT (target) from
CT (GAPDH). Expression levels relative to GAPDH were defined as: 2  CT
.
For the individual genes studied, expression data were standardized to aver-
aged, homologous message in naive mice (n   3–5); mRNA levels in the
BM of naive mice for GAPDH, HPRT, BAFF, CXCL2, CXCL12, SCF,
IL-1 , IL-7, IL-3, and GM-CSF vary over a  105-fold range (Table I).
Adoptive cell transfer. The ability of cells to localize in the BM was de-
termined by cell transfer. In brief, 2   107 BM cells from B6.SJL (CD45.1)
mice were incubated at 37 C in media containing PTX (0, 25, 100 ng/ml)
for 1 h, washed, and injected i.v. into naive, congenic C57BL/6 recipients
(CD45.2). Femoral and tibial BM cells were harvested 14 h later and labeled
with mAb specific for CD45.1, the RB6-8C5 Ag, CD11b, B220, or IgM.
Labeled CD45.1  cells were analyzed and enumerated by flow cytometry to
determine migration efficiencies.
Preparation of BM plasma. BMp was prepared by flushing femurs and
tibias from four mice with 500  l RPMI 1640 containing 0.5% BSA and 10
mM Hepes (migration media). Suspended cells were transferred into Ep-
pendorf-type centrifuge tubes; cells and debris were removed by repeated
(2 ) centrifugation at 5,000 g for 10 min.
Chemotaxis assays. BM cell chemotaxis was quantified in 24-well Trans-
well plates (Corning Costar) containing cells at 5   106/ml in migration
media. Mouse CXCL5 (PeproTech) or CXCL12  (PeproTech) or BMp
was added to migration media to specific concentrations, and 500- l aliquots
were placed in the lower chambers of plates. In some experiments, neutraliz-
ing Ab to mouse CXCL12 (100  g/ml; R&D Systems) or CXCL5 (50  g/
ml; R&D Systems) also was added. The 5- m pore inserts were placed on
the wells and preconditioned at 37 C for 1 h; BM cells (5   105) were
loaded (100  l) into the upper chambers. Cells were allowed to migrate into
the lower chamber for 4 h at 37 C. Subsequently, cells in the upper and
lower chambers were incubated with antibodies specific for B220 and the
RB6-8C5 Ag; labeled cells in duplicate cultures were enumerated by mi-
croscopy. In some experiments, the BM cells were pretreated with 100 ng/
ml PTX for 1 h at 37 C before their introduction into the migration plate.
Cell culture. c-Kit IgM B220  and c-Kit CD11b Gr-1  BM cells
were sorted and labeled (104) with CFSE IMS (Molecular Probes, Inc.) or
CMRA (Molecular Probes, Inc.). Labeled cells were cultured in established,
long-term BM cultures containing  2.5   103 stromal cells (23); 1 d after
co-culture, CFSE- and CMRA-labeled cells were analyzed by fluorescence
microscopy.
CMP or CLP (102) were cultured with the OP9 stromal cell line (31)
in the presence of specific cytokines to promote proliferation and differenti-
ation. For CMP cultures, 10 ng/ml IL-3 (R&D Systems) and GM-CSF
(PeproTech) were added; CLP cultures contained 10 ng/ml IL-7 (R&D
Systems) and Flt3-ligand (R&D Systems). After 5 d of culture, total myeloid
or lymphoid cell numbers were determined by microscopy.
ELISA for growth factors. SCF levels in BMp were determined in na-
ive, control, and adjuvant immunized mice (day 4) by the ELISA methods
described by Ueda and colleagues (8). In brief, 96-well plates were coated
with goat anti-SCF Ab (AF-455-NA); bound SCF was detected with bio-
tinylated with a second anti-SCF goat Ab (BAF455; both R&D Systems).
rMouse SCF (R&D Systems) was used to calibrate the assay and determine
its detection limit (1 pg/ml).
Statistics. Statistical significance (P   0.05) of data was determined by
Student’s t test.
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